Citations (36)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Bernard L. Marini, Julia Brown, Lydia Benitez, Emily Walling, Raymond J. Hutchinson, Rajen Mody, Rama Jasty Rao, Lynn Slagle, Lauren Bishop, Kristen Pettit, Dale L. Bixby, Patrick W. Burke & Anthony J. Perissinotti. (2019) A single-center multidisciplinary approach to managing the global Erwinia asparaginase shortage. Leukemia & Lymphoma 60:12, pages 2854-2868.
Read now
Read now
Chintan Vyas, Sandeep Jain, Gauri Kapoor, Anurag Mehta & Parul Takkar Chugh. (2018) Experience with generic pegylated L-asparaginase in children with acute lymphoblastic leukemia and monitoring of serum asparaginase activity. Pediatric Hematology and Oncology 35:5-6, pages 331-340.
Read now
Read now
Michael J. Burke, Meenakshi Devidas, Kelly Maloney, Anne Angiolillo, Reuven Schore, Kimberly Dunsmore, Eric Larsen, Len A. Mattano$suffix/text()$suffix/text(), Wanda Salzer, Stuart S. Winter, William Carroll, Naomi J. Winick, Mignon L. Loh, Elizabeth Raetz, Stephen P. Hunger & Archie Bleyer. (2018) Severe pegaspargase hypersensitivity reaction rates (grade ≥3) with intravenous infusion vs. intramuscular injection: analysis of 54,280 doses administered to 16,534 patients on children’s oncology group (COG) clinical trials. Leukemia & Lymphoma 59:7, pages 1624-1633.
Read now
Read now
Lynda Kwon Beaupin, Bruce Bostrom, Matthew J. Barth, Irene Franklin, Raven Jaeger, Priyanka Kamath, Brian Schreiber & Archie Bleyer. (2017) Pegaspargase hypersensitivity reactions: intravenous infusion versus intramuscular injection – a review. Leukemia & Lymphoma 58:4, pages 766-772.
Read now
Read now
Michael J. Burke & Susan R. Rheingold. (2017) Differentiating hypersensitivity versus infusion-related reactions in pediatric patients receiving intravenous asparaginase therapy for acute lymphoblastic leukemia. Leukemia & Lymphoma 58:3, pages 540-551.
Read now
Read now
Jing-fen Jin, Ling-ling Zhu, Meng Chen, Hui-min Xu, Hua-fen Wang, Xiu-qin Feng, Xiu-ping Zhu & Quan Zhou. (2015) The optimal choice of medication administration route regarding intravenous, intramuscular, and subcutaneous injection. Patient Preference and Adherence 9, pages 923-942.
Read now
Read now
Articles from other publishers (30)
Sarah Menig, Andrew Dinh, Jonathan Angus, Sarah Tucker, Kasey J. Leger, Teresa Rushing & Etan Orgel. (2023) Lack of benefit from premedication for pegylated asparaginase during pediatric acute lymphoblastic leukemia/lymphoma therapy: A side‐by‐side comparison. Pediatric Blood & Cancer 71:1.
Crossref
Crossref
Anja Möricke, Carmelo Rizzari, Julia Alten, Andishe Attarbaschi, Rita Beier, Andrea Biondi, Birgit Burkhardt, Nicole Bodmer, Joachim Boos, Gunnar Cario, Valentino Conter, Christian Flotho, Andreas Kulozik, Claudia Lanvers-Kaminsky, Georg Mann, Felix Niggli, Daniela Silvestri, Arend von Stackelberg, Martin Stanulla, Maria-Grazia Valsecchi, Martin Schrappe & Martin Zimmermann. (2023) Hypersensitivity Reactions to Native E. coli L-asparaginase in Children With Acute Lymphoblastic Leukemia Treated in Trial ALL-BFM 2000: Impact of Treatment Schedule and Type of Glucocorticoid in Induction. HemaSphere 7:6, pages e888.
Crossref
Crossref
Sara Zarnegar‐Lumley, Cosby A. StoneJr.Jr., Christine M. Smith, Laura L. Hall, Kate E. Luck, Grace Koo, Jessica H. Plager, Elizabeth J. Phillips & Debra L. Friedman. (2022) Oncologist counseling practice and COVID‐19 vaccination outcomes for patients with history of PEG‐asparaginase hypersensitivity. Pediatric Blood & Cancer 69:7.
Crossref
Crossref
Faisal ALMuhizi, Leticia De Las Vecillas Sanchez, Lucy Gilbert, Ana M. Copaescu & Ghislaine A. C. Isabwe. (2022) Premedication Protocols to Prevent Hypersensitivity Reactions to Chemotherapy: a Literature Review. Clinical Reviews in Allergy & Immunology 62:3, pages 534-547.
Crossref
Crossref
Andreas J. Bircher. 2022. Cutaneous Drug Hypersensitivity. Cutaneous Drug Hypersensitivity
3
9
.
Kathleen Busack. (2021) Pegaspargase: Two Pediatric Case Studies of Delayed Urticaria Preceding Anaphylactic Reactions Postadministration. Clinical Journal of Oncology Nursing 25:5, pages 511-513.
Crossref
Crossref
Meghan McCormick, Jillian Lapinski, Erika Friehling & Kenneth Smith. (2021) Premedication prior to PEG‐asparaginase is cost‐effective in pediatric patients with acute lymphoblastic leukemia. Pediatric Blood & Cancer 68:8.
Crossref
Crossref
Ana Paula Battistel, Bruno Simas da Rocha, Maitê Telles dos Santos, Liane Esteves Daudt & Mariana Bohns Michalowski. (2021) Allergic reactions to asparaginase: retrospective cohort study in pediatric patients with acute lymphoid leukemia. Hematology, Transfusion and Cell Therapy 43:1, pages 9-14.
Crossref
Crossref
Daiane Keller Cecconello, Ciliana Rechenmacher, Isabel Werlang, Priscila Pini Zenatti, Jose Andres Yunes, Ana Paula Alegretti, Claudia Lanvers-Kaminsky, Liane Esteves Daudt & Mariana Bohns Michalowski. (2020) Implementation of the asparaginase activity assessment technique for clinical use: experience of a Brazilian Center. Scientific Reports 10:1.
Crossref
Crossref
Daiane Keller Cecconello, Mariana Rodrigues de Magalhães, Isabel Cristina Ribas Werlang, Maria Lucia de Martino Lee, Mariana Bohns Michalowski & Liane Esteves Daudt. (2020) Asparaginase: an old drug with new questions. Hematology, Transfusion and Cell Therapy 42:3, pages 275-282.
Crossref
Crossref
Najeebah A Bade, Crystal Lu, Ciera L Patzke, Maria R Baer, Vu H Duong, Jennie Y Law, Seung T Lee, Edward A Sausville, Ann B Zimrin, Alison P Duffy, Justin Lawson & Ashkan Emadi. (2019) Optimizing pegylated asparaginase use: An institutional guideline for dosing, monitoring, and management. Journal of Oncology Pharmacy Practice 26:1, pages 74-92.
Crossref
Crossref
Alexander Karachunskiy, Gesche Tallen, Julia Roumiantseva, Svetlana Lagoiko, Almira Chervova, Arend von Stackelberg, Olga Aleinikova, Oleg Bydanov, Lyudmila Bajdun, Tatiana Nasedkina, Natalia Korepanova, Sergei Kuznetsov, Galina Novichkova, Marina Goroshkova, Dmitry Litvinov, Natalia Myakova, Natalia Ponomareva, Evgeniya Inyushkina, Konstantin Kondratchik, Julia Abugova, Larisa Fechina, Oleg Arakaev, Alexander Karelin, Vladimir Lebedev, Natalia Judina, Gusel Scharapova, Irina Spichak, Anastasia Shamardina, Olga Ryskal, Alexander Shapochnik, Alexander Rumjanzew, Joachim Boos & Günter Henze. (2019) Reduced vs. standard dose native E. coli-asparaginase therapy in childhood acute lymphoblastic leukemia: long-term results of the randomized trial Moscow–Berlin 2002. Journal of Cancer Research and Clinical Oncology 145:4, pages 1001-1012.
Crossref
Crossref
Haroon Hasan, Omar Mohammad Shaikh, Shahrad Rod Rassekh, A. Fuchsia Howard & Karen Goddard. (2018) Reply to: Comment on: Comparison of hypersensitivity rates to intravenous and intramuscular PEG-asparaginase in children with acute lymphoblastic leukemia: A meta-analysis and systematic review. Pediatric Blood & Cancer 65:8, pages e27106.
Crossref
Crossref
Hetal G. Dholaria, Amy Davies, Rishi S. Kotecha, Nicholas G. Gottardo & Thomas Walwyn. (2018) Comment on: Comparison of hypersensitivity rates to intravenous and intramuscular PEG-asparaginase in children with acute lymphoblastic leukemia: A meta-analysis and systematic review. Pediatric Blood & Cancer 65:8, pages e27065.
Crossref
Crossref
Rachel E. Rau, ZoAnn Dreyer, Mi Rim Choi, Wei Liang, Roman Skowronski, Krishna P. Allamneni, Meenakshi Devidas, Elizabeth A. Raetz, Peter C. Adamson, Susan M. Blaney, Mignon L. Loh & Stephen P. Hunger. (2018)
Outcome of pediatric patients with acute lymphoblastic leukemia/lymphoblastic lymphoma with hypersensitivity to pegaspargase treated with PEGylated
Erwinia
asparaginase, pegcrisantaspase: A report from the Children's Oncology Group
. Pediatric Blood & Cancer 65:3, pages e26873.
Crossref
Crossref
Van Thu Huynh & Sharon Bergeron. (2017) Asparaginase Toxicities: Identification and Management in Patients With Acute Lymphoblastic Leukemia
. Clinical Journal of Oncology Nursing 21:5, pages E248-E259.
Crossref
Crossref
David M. Charbonneau, Alexandra Aubé, Natalie M. Rachel, Vanessa Guerrero, Kevin Delorme, Julien Breault-Turcot, Jean-François Masson & Joelle N. Pelletier. (2017)
Development of
Escherichia coli
Asparaginase II for Immunosensing: A Trade-Off between Receptor Density and Sensing Efficiency
. ACS Omega 2:5, pages 2114-2125.
Crossref
Crossref
Pere Barba, José Luis Dapena, Pau Montesinos & Susana Rives. (2017) Asparaginasas en el tratamiento de la leucemia linfoblástica aguda. Medicina Clínica 148:5, pages 225-231.
Crossref
Crossref
Pere Barba, José Luis Dapena, Pau Montesinos & Susana Rives. (2017) Asparaginase use for the treatment of acute lymphoblastic leukemia. Medicina Clínica (English Edition) 148:5, pages 225-231.
Crossref
Crossref
Jennifer L. McNeer, Archie Bleyer, Valentino Conter & Wendy Stock. 2017. Cancer in Adolescents and Young Adults. Cancer in Adolescents and Young Adults
151
175
.
Haroon Hasan, Omar Mohammad Shaikh, Shahrad Rod Rassekh, A. Fuchsia Howard & Karen Goddard. (2017) Comparison of hypersensitivity rates to intravenous and intramuscular PEG-asparaginase in children with acute lymphoblastic leukemia: A meta-analysis and systematic review. Pediatric Blood & Cancer 64:1, pages 81-88.
Crossref
Crossref
Luigia Rossi, Francesca Pierigè, Antonella Antonelli, Noemi Bigini, Claudia Gabucci, Enrico Peiretti & Mauro Magnani. (2016) Engineering erythrocytes for the modulation of drugs' and contrasting agents' pharmacokinetics and biodistribution. Advanced Drug Delivery Reviews 106, pages 73-87.
Crossref
Crossref
Barbara Asselin. (2016) Immunology of infusion reactions in the treatment of patients with acute lymphoblastic leukemia. Future Oncology 12:13, pages 1609-1621.
Crossref
Crossref
Tamara MacDonald, Ketan Kulkarni, Mark Bernstein & Conrad V. Fernandez. (2016) Allergic Reactions With Intravenous Compared With Intramuscular Pegaspargase in Children With High-risk Acute Lymphoblastic Leukemia: A Population-based Study From the Maritimes, Canada. Journal of Pediatric Hematology/Oncology 38:5, pages 341-344.
Crossref
Crossref
Muaz Alrazzak, Lynda K. Beaupin, Peter Kinyoun & Matthew Barth. (2016) The Incidence of Hypersensitivity Reactions to Pegylated Asparaginase in Children With Acute Lymphoblastic Leukemia. Journal of Pediatric Hematology/Oncology 38:1, pages e16-e20.
Crossref
Crossref
Dalit Landesman-Milo, Shahd Qassem & Dan Peer. 2016. Nanomedicine. Nanomedicine
131
155
.
Lesleigh S. Abbott, Maria Zakova, Furqan Shaikh, Nisha Shewaramani, Angela Punnett & L. Lee Dupuis. (2015) Allergic Reactions Associated with Intravenous Versus Intramuscular Pegaspargase: A Retrospective Chart Review. Pediatric Drugs 17:4, pages 315-321.
Crossref
Crossref
. (2015) Pegaspargase. Reactions Weekly 1553:1, pages 236-236.
Crossref
Crossref
Luigia Rossi, Francesca Pierigè, Claudia Carducci, Claudia Gabucci, Tiziana Pascucci, Barbara Canonico, Sean M. Bell, Paul A. Fitzpatrick, Vincenzo Leuzzi & Mauro Magnani. (2014) Erythrocyte-mediated delivery of phenylalanine ammonia lyase for the treatment of phenylketonuria in BTBR-Pahenu2 mice. Journal of Controlled Release 194, pages 37-44.
Crossref
Crossref
Ruth Duncan. (2014) Polymer therapeutics: Top 10 selling pharmaceuticals — What next?. Journal of Controlled Release 190, pages 371-380.
Crossref
Crossref